week 2 on semaglutide What to Expect with Weight Loss in the First Once-Weekly Semaglutide in Adults with

Proper labeling avoids mistakes

Genetic testing for UGT1A1, GSTM1, GSTT1, NAT2, COMT, and SULT1A1 variants helps identify fixed (non-modifiable) conjugation bottlenecks that require lifelong compensatory strategies

Reported effects Significant weight loss (1015% body weight reduction) Improved glycemic control Reduced appetite and food intake Potential cardiovascular benefits Convenient once-weekly dosing Reported side effects Nausea, vomiting, diarrhea, constipation, abdominal pain (most common, typically mild) Injection-site reactions (redness, swelling, irritation) Hypoglycemia (less common, mainly when combined with insulin/sulfonylureas) Rare serious risks: pancreatitis, gallbladder disease, acute kidney injury Storage Lyophilised (unmixed) Freeze at -20 C (-4 F) After reconstitution Refrigerate at 28 C (35.646.4 F) and use within 28 days Supplies Important notes Always use a new, sterile insulin syringe for each injection and dispose of it properly in a sharps container

Yes, you can drink coffee while on Wegovy

Lee M, Kim MK, Kim SM, Park H, Park CG, Park HK

Importantly, Setria glutathione was shown not to suppress the body's own production of glutathione, making it a safe long-term choice